ArticleJournal of cellular and molecular medicine2026
Preliminary Clinical Outcomes of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Chronic Rhinosinusitis With Nasal Polyps: A Case Report.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a persistent inflammatory disease that may be resistant to medical management and recurs with traditional surgery. We report a 28-year-old male with a history of CRSwNP with comorbid asthma, who was resistant to all medical management, including saline irrigation, intranasal corticosteroids (INCS), and multiple courses of antibiotics, and elected against surgical intervention. Nasal endoscopy and imaging studies demonstrated bilateral polyposis and opacification of the ostia of all sinuses (Meltzer score 5 and Lund-Mackay score of 18). Serum IgE level remained significantly high. The patient declined surgical intervention but consented to treatment with human umbilical cord MSC-Exo (hUCMSC-Exo) intramucosal and intrapolyp injections while continuing his standard regimen of saline irrigation and INCS. The treatment was well tolerated, with only reported mild and transient epistaxis. At follow-up after two months, the patient experienced a rapid decrease in SNOT-22 score (56-6). However, the symptomatic relief had abated, and the symptoms returned gradually but did not reach baseline (SNOT-22 increased to 41). Conversely, asthma control remained stable during this time, and the serum IgE level showed an overall negative trend. Given the single-patient, uncontrolled design with concurrent INCS and short follow-up, causality cannot be inferred. This case supports feasibility/tolerability and generates hypotheses for larger controlled studies of this cell-free approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.